Authors: MCCABE CJ AKEHURST RL KIRSCH J WHITFIELD M BACKHOUSE M WOOLF AD SCOTT DL EMERY P HASLOCK M

Citation: Cj. Mccabe et al., CHOICE OF NSAID AND MANAGEMENT STRATEGY IN RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS - THE IMPACT ON COSTS AND OUTCOMES IN THE UK, PharmacoEconomics, 14(2), 1998, pp. 191-199

Authors: SCHULMAN KA BUXTON M GLICK H SCULPHER M GUZMAN G KONG J BACKHOUSE M MAUSKOPF J BELL L EISENBERG JM CALIFF RM MCKENNA WJ HARRELL FE URETSKY BF ADAMS KF SWEDBERG KB GHEORGHIADE M ZANNAD F HANDBERG E DARIUS H SOLERSOLER J WHEELER WS ARMSTRONG PW PATTERSON H MURALI S BUTMAN S KIRLIN PC MILLER LW JAFRI S RICH S COSTANZONORDIN MR MCGOON M HOSENPUD JD RATKOVEC R BRUNDAGE B PRITZKER M BOURGE R REEVES W FORGOSH L VENTURA H YOUNG JB MANCINI D MILLS RM LIMACHER MC LEE F REVKIN J KALBFLEISCH JM FISHBEIN D PRESSLER M HAEUSSLEIN E KARLSBERG RP OCONNELL J LEJEMTEL TH THOMAS HM SMITH WB MCIVOR M CINTRON GB HAGER WD MESSINEO FC DOUGHERTY JE HASSAPOYANNES C HOOD W MCGREW F SANFORD CF OCONNER CM HOBBS RE YARDLEY D KAY R MINOTTI J EASTBURN TE LINDENFELD J LITMAN G WICKEMEYER W HORTON S GILBERT EM EICHORN E RIBNER HS CORDER C PHILBIN E NOCERO M ELKAYAM U JESSUP M CRAWFORD M CARSON P REDDY HK KLAPHOLZ M HEYWOOD JT SALINGER M KARLSBERG R BUSH D HUNTER C WOHNS D EISENBERG P WINSTON S BUTCHER C MASSIN E WYNNE J TONKON M SPACCAVENTO L DIVER D GHALI J HUTCHINS S ANAND I BEANLANDS D KOSTUK W PFLUGFELDER P LANGLEBEN D LATOUR P MIZGALA H RICCI D MANYARI D DARGIE HJ DAVIDSON C SWANTON H HUBNER PJB OAKLEY D BROOKS N JENNINGS K GREENBAUM RA PENNY WJ NICHOLLS P WALSH M SUGRUE D FENNELL W HORGAN JH JONDEAU G CASTAIGNE A LEMAREC H WALGER P PARK JW DEBERRAZUETA JR MOL MG SANCHEZ MAG CAPONNETTO S MAGNANI B GALIE N DEVITA C MASERI A BAGGER JP REMES J WALDENSTROM A SCHAUFELBERGER M DIENSTI F SIMOONS ML KLEIN W PACHER R KEOGH A HARLEY A

Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713

Authors: SCHULMAN KA GLICK H BUXTON M SCULPHER M BACKHOUSE M BELL L EISENBERG JM

Citation: Ka. Schulman et al., THE ECONOMIC-EVALUATION OF THE FIRST STUDY - DESIGN OF A PROSPECTIVE ANALYSIS ALONGSIDE A MULTINATIONAL PHASE-III CLINICAL-TRIAL, Controlled clinical trials, 17(4), 1996, pp. 304-315

Authors: FENN P MCGUIRE A BACKHOUSE M JONES D

Citation: P. Fenn et al., MODELING PROGRAM COSTS IN ECONOMIC-EVALUATION, Journal of health economics, 15(1), 1996, pp. 115-125

Authors: FENN P MCGUIRE A PHILLIPS V BACKHOUSE M JONES D

Citation: P. Fenn et al., THE ANALYSIS OF CENSORED TREATMENT COST DATA IN ECONOMIC-EVALUATION, Medical care, 33(8), 1995, pp. 851-863

Authors: DRUMMOND M BACKHOUSE M

Citation: M. Drummond et M. Backhouse, ASSESSING THE ECONOMIC-BENEFITS OF ANTIHERPES THERAPY, Journal of medical virology, 1993, pp. 51-57